Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialDavid A. Palma, Suresh Senan, Suzanne Currie et al.|The Lancet|2019Cited by 1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A. Palma, Suresh Senan, Karen Moore et al.|Journal of Clinical Oncology|2020Cited by 1.2k
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung CancerBen J. Slotman, Suresh Senan, Corinne Faivre‐Finn et al.|New England Journal of Medicine|2007Cited by 1.1k
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysisDavid A. Palma, George Rodrigues, Suresh Senan et al.|International Journal of Radiation Oncology*Biology*Physics|2013Cited by 673
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trialBen J. Slotman, Suresh Senan|The Lancet|2014Cited by 587